[West Nile meningoencephalitis in an immunocompromised patient].
Dequatre
N
N
Service de Neurologie et Pathologie du Mouvement, Hôpital Roger Salengro, CHRU Lille, EA 2683, IFR 114, MENRT, Lille.
Moreau
C
C
Lacour
A
A
Degardin
A
A
Lionet
A
A
Devos
D
D
Destée
A
A
Defebvre
L
L
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D003128:Coma / Q000209:etiology; D016572:Cyclosporine / Q000009:adverse effects / Q000627:therapeutic use; D015259:Dopamine Agents / Q000627:therapeutic use; D004797:Enzyme-Linked Immunosorbent Assay; D017809:Fatal Outcome; D006801:Humans; D016867:Immunocompromised Host; D007074:Immunoglobulin G / Q000276:immunology; D007075:Immunoglobulin M / Q000032:analysis; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology; D007980:Levodopa / Q000627:therapeutic use; D008279:Magnetic Resonance Imaging; D008297:Male; D008590:Meningoencephalitis / Q000276:immunology / Q000473:pathology* / Q000821:virology; D009173:Mycophenolic Acid / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use; D011239:Prednisolone / Q000627:therapeutic use; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014901:West Nile Fever / Q000276:immunology / Q000473:pathology* / Q000821:virology; D014902:West Nile virus / Q000235:genetics; D055815:Young Adult
D000893:Anti-Inflammatory Agents; D015259:Dopamine Agents; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007166:Immunosuppressive Agents; D007980:Levodopa; D016572:Cyclosporine; D011239:Prednisolone; D009173:Mycophenolic Acid